[go: up one dir, main page]

AU2103495A - Method for prediction of premature delivery using estetrol (e4) as an indicator - Google Patents

Method for prediction of premature delivery using estetrol (e4) as an indicator

Info

Publication number
AU2103495A
AU2103495A AU21034/95A AU2103495A AU2103495A AU 2103495 A AU2103495 A AU 2103495A AU 21034/95 A AU21034/95 A AU 21034/95A AU 2103495 A AU2103495 A AU 2103495A AU 2103495 A AU2103495 A AU 2103495A
Authority
AU
Australia
Prior art keywords
estetrol
prediction
indicator
premature delivery
premature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21034/95A
Inventor
Vivian Dullien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biex Inc
Original Assignee
Biex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biex Inc filed Critical Biex Inc
Publication of AU2103495A publication Critical patent/AU2103495A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/42—Gynaecological or obstetrical instruments or methods

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU21034/95A 1994-08-04 1995-03-17 Method for prediction of premature delivery using estetrol (e4) as an indicator Abandoned AU2103495A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US285796 1988-12-16
US28579694A 1994-08-04 1994-08-04
PCT/US1995/003442 WO1996003929A1 (en) 1994-08-04 1995-03-17 Method for prediction of premature delivery using estetrol (e4) as an indicator

Publications (1)

Publication Number Publication Date
AU2103495A true AU2103495A (en) 1996-03-04

Family

ID=23095728

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21034/95A Abandoned AU2103495A (en) 1994-08-04 1995-03-17 Method for prediction of premature delivery using estetrol (e4) as an indicator

Country Status (2)

Country Link
AU (1) AU2103495A (en)
WO (1) WO1996003929A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6678669B2 (en) 1996-02-09 2004-01-13 Adeza Biomedical Corporation Method for selecting medical and biochemical diagnostic tests using neural network-related applications
JP2005503530A (en) * 1999-09-10 2005-02-03 バイエックス，インコーポレイティド Monitoring hormone replacement therapy
US6174665B1 (en) 1999-09-10 2001-01-16 Biex, Inc. Hormone replacement therapy monitoring
PT1390040E (en) * 2001-05-18 2007-04-30 Pantarhei Bioscience Bv Pharmaceutical composition for use in hormone replacement therapy
EP1260225A1 (en) * 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. A pharmaceutical composition for use in hormone replacement therapy
ES2296943T3 (en) 2001-05-23 2008-05-01 Pantarhei Bioscience B.V. SYSTEM OF ADMINISTRATION OF A TETRAHYDROXYLED STROGEN DRUG INTENDED FOR HORMONAL CONTRACEPTION.
US7871995B2 (en) 2001-05-23 2011-01-18 Pantarhei Bioscience B.V. Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
EP1446128B1 (en) 2001-11-15 2006-12-06 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
EP1511496B1 (en) 2002-06-11 2006-09-27 Pantarhei Bioscience B.V. Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
WO2003103685A1 (en) 2002-06-11 2003-12-18 Pantarhei Bioscience B.V. A method of treating human skin and a skin care composition for use in such a method
PT1526856E (en) 2002-07-12 2008-04-11 Pantarhei Bioscience Bv Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
DK1556058T3 (en) 2002-10-23 2008-03-03 Pantarhei Bioscience Bv Pharmaceutical compositions comprising oestetrol derivatives for use in cancer therapy
WO2007086067A1 (en) * 2006-01-30 2007-08-02 Diagnostic Technologies Ltd. Method for monitoring tocolytic treatment
WO2008085038A2 (en) 2007-01-08 2008-07-17 Pantarhei Bioscience B.V. Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
ES2376793T3 (en) 2007-07-19 2012-03-16 Pantarhei Bioscience B.V. Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
SMT202200102T1 (en) 2015-06-18 2022-05-12 Estetra Srl Orodispersible dosage unit containing an estetrol component
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (en) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 Compounds and their uses for alleviating menopause-associated symptoms
JOP20200260A1 (en) 2018-04-19 2019-10-19 Estetra Sprl Compounds and their uses for alleviating menopause-associated symptoms
TWI893101B (en) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 Contraceptive compositions with reduced adverse effects

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223295B (en) * 1987-08-14 1990-09-19 Boehringer Biochemia Srl IMMUNODIAGNOSTIC DEVICE AND METHOD
US5096830A (en) * 1987-11-17 1992-03-17 Adeza Biomedical Corporation Preterm labor and membrane rupture test
US5028535A (en) * 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5370135A (en) * 1993-10-13 1994-12-06 Biex, Inc. Use of estriol measurement to monitor tocolytic therapy

Also Published As

Publication number Publication date
WO1996003929A1 (en) 1996-02-15

Similar Documents

Publication Publication Date Title
AU2103495A (en) Method for prediction of premature delivery using estetrol (e4) as an indicator
AU1231895A (en) Method for making soft high bulk tissue
EP0729997A3 (en) Method for preparation of block copolysiloxanecarbonates
AU2149497A (en) Optimizing doses of contrasting agent for imaging diagnostic methods
AU6046998A (en) Method of measuring physiological function
AU5251998A (en) Method of testing for periodontal disease
AU6788690A (en) Gas removable pump for liquid
AU5933990A (en) Method for generating maps
AU638524B2 (en) Method of determining fructosamine
AU634315B2 (en) Gas removable pump for liquid
AU6422494A (en) Method for ultra-trace level analysis of water
AU2532295A (en) Method of genetic testing
AU4249793A (en) An improved method for preparation of glycosides
AU6215290A (en) Method for activating protein c
AU6511890A (en) Method for the preparation of an immunizing composition
AU1710095A (en) Method for isolating of wheyproteins
GB2293986B (en) Method of preparing blood plasma for analysis
AU6231096A (en) Apparatus for enclosing part of an elongate object
AU1597095A (en) Method for making alkyl polyglycosides
AU4919499A (en) Method for preparing an activator for the polymerisation of olefins
AU626652B2 (en) Apparatus for separate injection of reagent
AU6843496A (en) Method for replacing the background of an image
AU5983090A (en) Method for salting meat
AU5641298A (en) Method for the preparation of pure carboxyethyl germanium sesquixide
AU8024298A (en) Method for isolating an intracellular substance